SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Beryl Drugs Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524606 INE415H01017 18.6259045 Not Listed 0 9.78 0 0.03 10
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales3.785.124.79
Other Operating Income0.070.040.04
Other Income 0.000.000.00
Total Income3.855.164.84
Total Expenditure 4.054.424.28
PBIDT-0.200.730.55
Interest 0.090.080.10
PBDT-0.290.650.45
Depreciation0.320.390.38
Tax-0.180.110.15
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.260.14-0.10
Reported Profit After Tax-0.170.010.02
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.170.010.02
    
EPS (Unit Curr.)-0.330.020.04
EPS (Adj) (Unit Curr.)-0.330.020.04
Calculated EPS (Unit Curr.)-0.330.020.04
Calculated EPS (Adj) (Unit Curr.)-0.330.020.04
Calculated EPS (Ann.) (Unit Curr.)-1.320.070.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)-1.320.070.17
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.075.075.07
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-5.2914.2611.48
PBDTM(%)-7.6712.709.39
PATM(%)-4.500.200.42